Gyre Therapeutics, Inc. GYRE Statutory Reserve
Statutory Reserve at other companies
Other financials
Where this comes from
Reported directly by Gyre Therapeutics, Inc. in its filing.
Tagged under the XBRL concept gyre:StatutoryReserve.
The official record: Gyre Therapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Gyre Therapeutics, Inc.'s statutory reserve.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Gyre Therapeutics, Inc.'s statutory reserve?
- Gyre Therapeutics, Inc. (GYRE) reported statutory reserve of $3.65M in Q1 2026.
- How has Gyre Therapeutics, Inc.'s statutory reserve changed year-over-year?
- Gyre Therapeutics, Inc.'s statutory reserve increased by 17.8% year-over-year, from $3.1M to $3.65M.
- What is the long-term trend for Gyre Therapeutics, Inc.'s statutory reserve?
- Over 3 years (2022 to 2025), Gyre Therapeutics, Inc.'s statutory reserve has grown at a 5.2% compound annual growth rate (CAGR), from $2.66M to $3.1M.
- What does statutory reserve mean?
- This represents a portion of equity that is legally restricted from distribution to shareholders, often mandated by regulatory requirements or corporate bylaws. It serves as a buffer to protect creditors and ensure the company maintains a minimum level of capital stability. Understanding this reserve is important for evaluating the company's dividend-paying capacity and its adherence to regulatory capital maintenance standards.